Fingerprint
Dive into the research topics of 'Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States
Edward V. Loftus, Xiaoyun Pan, Pete Zurawski, Parvez Mulani, Jingdong Chao
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations